V8 Peptides — Engineered Performance
Research Library
Selank Mechanisms: GABA, Enkephalin and Cytokine Data
SelankMechanism

Selank Mechanisms: GABA, Enkephalin and Cytokine Data

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What are the proposed mechanisms of Selank in the research literature? Published work describes Selank at the pathway level rather than through one receptor. Three strands recur: changes in expression of genes involved in GABAergic neurotransmission in rat frontal cortex (with a more modest cell-line result), inhibition of enkephalin-degrading enzymes in human serum, and changes in expression of inflammation-related genes in mouse spleen. Each strand comes from a different system, so they are best read as separate hypotheses about the tuftsin-derived heptapeptide rather than one proven mechanism. Selank is supplied for laboratory research use only.

How to read mechanism claims for a peptide with no single receptor

Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, built from the tuftsin sequence Thr-Lys-Pro-Arg with a Pro-Gly-Pro tail. The Selank product page lists the formula C33H57N11O9, a 10 mg size and ≥98% HPLC purity. Tuftsin itself was described in 1970 as a natural phagocytosis-stimulating peptide.[1]

Unlike compounds with a defined receptor, Selank has no universally accepted single target, so mechanism claims depend on readouts: which genes, which enzymes, which cells. This article takes each published readout in turn and states what was measured, the system, and what the authors concluded. The wider background is in the Selank research overview.

Mechanism strands at a glance

StrandSystemWhat was measuredSource
GABAergic gene expressionRat frontal cortex84 neurotransmission-related genes by real-time PCR after Selank or GABAVolkova 2016[2]
GABAergic gene expressionIMR-32 human neuroblastoma cells84 GABAergic-system genes by qPCR after Selank, GABA, olanzapine or combinationsFilatova 2017[3]
Enkephalin turnoverHuman serumActivity of enkephalin-degrading enzymes with Semax and Selank (IC50 about 20 µM for Selank)Kost 2001[4]
Inflammation-related genesMouse spleen84 inflammation genes 6 and 24 h after a single administration (100 µg/kg); 34 changedKolomin 2011[5]
Time courseMouse spleenC3, Casp1, Il2rg and Xcr1 mRNA over time, Selank and the Gly-Pro fragmentKolomin 2014[6]

Each row has a different species, tissue and endpoint, which is why the strands cannot be added together into a single mechanism.

Strand 1: the GABAergic hypothesis

Volkova and colleagues began from the observation that clinical studies of Selank had noted a spectrum of effects resembling that of classical benzodiazepines, and asked whether the molecular basis might be similar. They analyzed 84 genes involved in neurotransmission, including GABA receptor subunits, transporters, ion channels and dopamine and serotonin receptors, in the frontal cortex of rats 1 and 3 hours after administration of Selank or GABA (300 µg/kg), using real-time PCR. Expression changes after Selank and after GABA correlated positively within 1 hour, Selank altered a number of genes involved in neurotransmission, and the authors concluded that one possible molecular mechanism is associated with allosteric modulation of the GABAergic system.[2]

Filatova and colleagues moved the question into a human cell line, the IMR-32 neuroblastoma line, and analyzed 84 genes of the GABAergic system by qPCR after Selank, GABA, olanzapine and combinations. The result was more restrained: Selank alone changed none of the mRNA levels studied, so it had no direct effect on those genes in this cell line. Together with GABA, however, Selank nearly completely suppressed the changes that GABA produced, and with olanzapine it altered more genes than olanzapine alone. The authors read this as partial support for the idea that the peptide may affect the interaction of GABA with GABA-A receptors.[3]

Reading the two papers together, the GABAergic hypothesis rests on a gene-expression pattern in rat cortex that correlates with the response to GABA, and on a cell-line result in which Selank modifies the effect of GABA rather than acting alone. Direct receptor-binding or electrophysiology data are a different type of evidence and are not provided by gene-expression studies.

Strand 2: enkephalin-degrading enzymes

Kost and colleagues reported a dose-dependent inhibition of the enkephalin-degrading enzymes of human serum by the heptapeptides Semax and Selank, with IC50 values of about 10 µM for Semax and 20 µM for Selank, more pronounced than for puromycin and bacitracin; pentapeptide fragments also inhibited, while tri-, tetra- and hexapeptide fragments did not.[4] The authors suggested that one mechanism of biological activity of these peptides may relate to this inhibition, noting that the enzymes also degrade other regulatory peptides. This is a biochemical result in serum, not in intact brain. An enzyme-inhibition readout needs the usual controls: a no-peptide arm, a positive inhibitor, a range of substrate concentrations and a check that the peptide is not itself a competing substrate. The enzyme data should also be kept apart from the gene-expression data, since inhibition in serum says nothing about transcription in cortex.

Strand 3: inflammation-related genes

Because Selank derives from tuftsin, an immunomodulatory peptide, several studies looked at immune readouts. Kolomin and colleagues analyzed 84 inflammation-related genes (chemokines, cytokines and their receptors) in mouse spleen 6 and 24 hours after a single intraperitoneal administration of Selank (100 µg/kg) and found significant changes in 34 of them, including the Bcl6 gene, which also changed after two Selank fragments.[5] A follow-up paper tracked C3, Casp1, Il2rg and Xcr1 over time after Selank or its short fragment Gly-Pro: C3 mRNA fell about 3-fold within 30 minutes, Casp1 showed a wave-like pattern, and the profiles after Selank and Gly-Pro often coincided, which the authors took to indicate a contribution of the dipeptide to the final effect.[6]

The time-course design matters: transcript changes after a single exposure tend to be transient, and a readout at one time point can miss or exaggerate an effect. A laboratory repeating this should sample several time points and include a vehicle arm at every one of them.

What the three strands share and where they diverge

QuestionGABAergic strandEnkephalin strandInflammation strand
Level of evidenceTranscript changesEnzyme activityTranscript changes
SystemRat brain, human cell lineHuman serumMouse spleen
Direct target shown?NoEnzymes inhibitedNo
Time dimension1 h and 3 hAssay-dependentTime-course reported
Best next controlReceptor binding or electrophysiologyIntact-tissue assayProtein-level cytokine measurement

The shared feature is that all three are indirect. None identifies a receptor to which Selank binds with defined affinity, which is why the pillar describes the mechanism as described at the pathway level.

Planning a mechanism experiment: practical points

  • Pick one strand and state it. A gene-expression panel, an enzyme assay and a cytokine assay answer different questions.
  • Include the reference molecule. The rat study used GABA as a comparator;[2] the cell study used GABA and olanzapine.[3] A reference arm shows whether a Selank pattern resembles a known one.
  • Use several time points. The published designs sampled at 1 and 3 hours or reported temporal dynamics.[2][6]
  • Do the molar arithmetic. The formula weight is about 752 g/mol. Concentration (mol/L) = mass (mg) ÷ molecular weight (g/mol) ÷ volume (mL) gives mmol/mL; use the calculator and record the result. Published doses in µg/kg are animal-study amounts and are not converted here.
  • Verify the material. Compare each lot with the COA library where one is published and read Selank purity testing.

Limits of the current evidence

Three limits apply to every strand. First, gene-expression and enzyme-activity data show association, not binding: a change in transcripts after a peptide is applied can be a secondary response to many upstream events. Second, the animal work used rats and mice, and the cell work used a single human neuroblastoma line in which Selank alone had no effect on the genes studied, so results should not be generalized across species or cell types without testing. Third, the studies are small, from a limited number of groups, and independent replication of each strand would strengthen it. A careful reading of the literature therefore reads the GABAergic, enkephalin and inflammatory strands as hypotheses with preliminary support. See also Selank vs Semax: research comparison for how a related peptide was studied with the same enzyme assay.

Handling and research-use statement

Per the product page the supplied form is lyophilized powder in a sealed clear glass vial, stored at 2-8 °C with −20 °C for long-term storage, protected from heat, moisture and light. Prefer single-use portions of reconstituted stock. All material discussed here is supplied for laboratory research use only; not for human or animal consumption, and not a drug, food or cosmetic.

Related reading

Frequently asked questions

Does Selank have a known receptor?

No single receptor is universally accepted. Published work describes pathway-level effects on GABAergic genes, enkephalin-degrading enzymes and inflammation-related genes.[2][3][4][5]

What did the rat gene-expression study measure?

The expression of 84 neurotransmission genes in frontal cortex 1 and 3 hours after Selank or GABA (300 µg/kg), by real-time PCR.[2]

Is the GABA link a binding result?

No. It is a gene-expression correlation, and the authors raise allosteric modulation of the GABAergic system as a possible mechanism.[2]

What was found in the human cell line?

Selank alone changed none of 84 GABAergic-system genes in IMR-32 cells, but with GABA it nearly suppressed the changes GABA produced.[3]

What is the enkephalin finding?

Semax and Selank inhibited enkephalin-degrading enzymes of human serum, with IC50 values of about 10 and 20 µM.[4] It is a biochemical result, not an intact-brain result.

Why does the tuftsin link matter?

Selank contains the tuftsin sequence Thr-Lys-Pro-Arg, a natural phagocytosis-stimulating peptide,[1] which is why immune readouts were studied.

Why sample at several time points?

Transcript changes can be transient, so one time point can miss or exaggerate an effect. The cited designs used 1 and 3 hours or a time course.[2][6]

How do I convert a stock to molar terms?

Divide mass in mg by 752 g/mol for mmol, then by the volume in mL for mmol/mL; the calculator does it.

How is Selank stored?

2-8 °C, or −20 °C for long-term, protected from heat, moisture and light, per the product page.

Is Selank intended for people or animals?

No. It is supplied for laboratory research use only; not for human or animal consumption.

Related reading: Selank Structure and Sequence: Tuftsin Plus Pro-Gly-Pro.

References

  1. Najjar VA, et al. 'Tuftsin': a natural phagocytosis stimulating peptide. Nature. 1970. doi:10.1038/228672a0
  2. Volkova A, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016. doi:10.3389/fphar.2016.00031 PMID: 26924987
  3. Filatova E, et al. GABA, Selank, and olanzapine affect the expression of genes involved in GABAergic neurotransmission in IMR-32 cells. Front Pharmacol. 2017. doi:10.3389/fphar.2017.00089 PMID: 28293190
  4. Kost NV, et al. Semax and Selank inhibit the enkephalin-degrading enzymes of human serum. Russ J Bioorg Chem. 2001. doi:10.1023/a:1011373002885 PMID: 11443939
  5. Kolomin T, et al. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Regul Pept. 2011. doi:10.1016/j.regpep.2011.05.001 PMID: 21609736
  6. Kolomin T, et al. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action. Mol Immunol. 2014. doi:10.1016/j.molimm.2013.11.002 PMID: 24291245

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.